ESC/EAS guidelines for the detection, prevention, and treatment of individuals at risk of a first myocardial infarction: effect of 5 years of updates and the new SCORE2.

David SulmanMichel ZeitouniJohanne SilvainMathieu KerneisPaul GuedeneyOlivier BarthélémyDelphine BrugierPierre SabouretBenoit LattucaEmilie MertensJulianne PossonNiki ProcopiTomy SalloumJean Philippe Collet Gilles Montalescot

Published in: European heart journal. Cardiovascular pharmacotherapy (2022)

The 2021 ESC guidelines improved the detection and treatment of individuals at risk for a first myocardial infarction. In secondary prevention, 70% of patients kept LDL-C levels above 55 mg/dL: increasing the statin dose and adding ezetimibe were the most frequently recommended therapeutic actions.

Keyphrases

end stage renal disease
left ventricular
cardiovascular disease
ejection fraction
newly diagnosed
coronary artery disease
clinical practice
label free
patient reported outcomes
smoking cessation